ENTRY       D11707                      Drug
NAME        Golodirsen (USAN/INN);
            Vyondys 53 (TN)
PRODUCT     VYONDYS 53 (Sarepta Therapeutics)
FORMULA     C305H481N138O112P25
EXACT_MASS  8642.9625
MOL_WEIGHT  8647.2841
REMARK      ATC code: M09AX08
            Product: D11707<US>
EFFICACY    Translation inhibitor
  DISEASE   Duchenne muscular dystrophy (DMD variant amenable to exon 53 skipping) [DS:H01963]
  TYPE      Antisense oligonucleotide
TARGET      DMD* [HSA_VAR:1756v1] [HSA:1756] [KO:K10366]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
               M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
                M09AX Other drugs for disorders of the musculo-skeletal system
                 M09AX08 Golodirsen
                  D11707  Golodirsen (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Golodirsen
               D11707  Golodirsen (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Cellular process
               Cytoskeleton
                DMD* [HSA_VAR:1756v1]
                 D11707  Golodirsen (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11707
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11707
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D11707
DBLINKS     CAS: 1422959-91-8
            PubChem: 405226573
///
